Source: Archiv der Pharmazie. Unidade: IQSC
ABNT
MARTINS, Felipe Cardoso Prado et al. Exploring Nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2. Archiv der Pharmazie, v. 358, p. e70158, 2025Tradução . . Disponível em: https://doi.org/10.1002/ardp.70158. Acesso em: 03 dez. 2025.APA
Martins, F. C. P., Lang, J., Rocho, F. dos R., Wang, X., Bonatto, V., Lameira, J., et al. (2025). Exploring Nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2. Archiv der Pharmazie, 358, e70158. doi:10.1002/ardp.70158NLM
Martins FCP, Lang J, Rocho F dos R, Wang X, Bonatto V, Lameira J, Klein C, Montanari CA. Exploring Nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2 [Internet]. Archiv der Pharmazie. 2025 ; 358 e70158.[citado 2025 dez. 03 ] Available from: https://doi.org/10.1002/ardp.70158Vancouver
Martins FCP, Lang J, Rocho F dos R, Wang X, Bonatto V, Lameira J, Klein C, Montanari CA. Exploring Nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2 [Internet]. Archiv der Pharmazie. 2025 ; 358 e70158.[citado 2025 dez. 03 ] Available from: https://doi.org/10.1002/ardp.70158
